Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

New understanding and treatments for hair loss are improving, but more research is needed.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Chromosomal differences affect how muscle cells respond to testosterone.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Ganoderma lucidum may help treat enlarged prostate in rats.

Finasteride helps protect brain in old male rats.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Chinese medicine may help hair growth and reduce hair loss in androgenetic alopecia.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Sex steroids produced in the hippocampus are crucial for brain functions like memory and learning in rodents.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.